Monday-Friday 6:00am – 5:00pm | Saturday 6:00am – 12:00pm
Interview on “Un Buen Día” at WIPR
September 3, 2024Innovations in acquiring technology and artificial intelligence to support the pathologist in his diagnostic decision.
Validation and 3 years of clinical experience in using an AI algorithm as a second read system for prostate cancer diagnosis
May 29, 2024Prostate cancer ranks as the most frequently diagnosed cancer in men in the USA, with significant mortality rates.
CorePlus Expands Use of AI Tools to Routine Cancer Diagnosis
May 29, 2024Back in June 2020, CorePlus Servicios Clínicos y Patológicos LLC (Carolina, Puerto Rico) became the first independent lab in the…
High risk HPV testing for cervical cancer screening in a Puerto Rican population
May 29, 2024The human papillomavirus (HPV) is the principal cause of cervical cancer and can cause up to six different types of…
Comparative analysis of onychomycosis in Puerto Rico using molecularand conventional approaches
May 29, 2024Onychomycosis is responsible for 50% of all nail infections. It is the most frequent nail ailment in adults and is…
CorePlus Announces the Deployment of Artificial Intelligence Algorithm for 100% QC of Pap Tests
May 16, 2024CorePlus is the first laboratory in the world to operationalize the Techcyte AI algorithm.
Using AI in Pathology to Benefit Patients w/ Mariano de Socarraz
May 13, 2024Watch this amazing conversation between Aleksandra Zuraw and Mariano de Socarraz discussing the transformative story of CorePlus.
Health Industry Summit 2024 by the Puerto Rico Manufacturers Association
February 28, 2024Mariano de Socarraz, founder and CEO of CorePlus, during the Health Industry Summit 2024 of the Puerto Rico Manufacturers Association.…
Unprecedented Patient Care: CorePlus Uses AI for 100% QC in Cervical Cytology
January 22, 2024Insights into the shift from manual microscopy to digital diagnostics using Techcyte's AI platform.
CorePlus leading the way for AI adoption in digital pathology
January 5, 2024Watch this interview with CorePlus CEO and CMO to learn why they have chosen to use AI in primary diagnosis.